CENIC stands for the Center for the Evaluation for Nicotine in Cigarettes. It is a multi-site study for people who are willing to try cigarettes with varying levels of nicotine. The FDA will use this information to regulate tobacco products with the goal of improving public health.
A clinical research study designed to test high and low dose Topiramate to see if this medication can be used to decrease drinking behaviors and increase smoking abstinence.
The goal of this research study is to learn more about the bacteria found in the digestive tract and if these bacteria influence the brain's response to food images and eating behavior.
The goal of this research study is to learn more about how smoker's brains respond to cues in their environment and how smoking a cigarette influences brain responses. Brain responses will be measured using a functional magnetic resonance imaging (fMRI) scanner.
The purpose of this study is to develop a task that will allow us to measure how the individual's brain reacts to different stimuli, such as images of food.
The goal of this clinical research study is to learn if the combination of the nicotine patch and nicotine lozenge is more effective at helping people to quit smoking or reduce the amount they smoke than Chantix (varenicline). Researchers also want to learn if it is more effective to leave people on their original treatment even if they do not quit smoking versus increasing their treatment dose or switching them to another treatment.
For questions about our lab, please contact:
- Regina Richards
Senior Administrative Assistant
- Altoya Bazile-Robertson
Interested in quitting smoking? For more information about any of our smoking cessation studies, call 713-792-2265.
Interested in participating in our non-quit research studies? Call the non-quit line at 713-794-4763 for more information.